Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD).

Full DD Report for IRWD

You must become a subscriber to view this report.


Recent News from (NASDAQ: IRWD)

Ironwood Pharmaceuticals, Inc. (IRWD) CEO Peter Hecht on Q3 2018 Results - Earnings Call Transcript
Ironwood Pharmaceuticals, Inc. (IRWD) Q3 2018 Earnings Conference Call November 06, 2018 08:30 AM ET Executives Meredith Kaya - Vice President, Investor Relations and Corporate Communications Peter Hecht - Chief Executive Officer Thomas McCourt - Senior Vice President, Marketing ...
Source: SeekingAlpha
Date: November, 06 2018 17:13
Ironwood Pharmaceuticals, Inc. 2018 Q3 - Results - Earnings Call Slides
The following slide deck was published by Ironwood Pharmaceuticals, Inc. in conjunction with their 2018 Q3 earnings Read more ...
Source: SeekingAlpha
Date: November, 06 2018 11:10
Ironwood Pharmaceuticals misses by $0.18, misses on revenue
Ironwood Pharmaceuticals (NASDAQ: IRWD ): Q3 Non-GAAP EPS of -$0.38 misses by $0.18 ; GAAP EPS of -$1.14 misses by $0.94 . More news on: Ironwood Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: November, 06 2018 08:17
Ironwood Pharmaceuticals Provides Third Quarter 2018 Investor Update
– LINZESS ® (linaclotide) U.S. net sales increased 7% to $205 million in 3Q 2018 vs 3Q 2017 – – Ironwood revenue of $66 million in 3Q 2018, which includes a $30 million reduction due to LINZESS change in estimate as reported to Ironwood by Allergan ȁ...
Source: Business Wire
Date: November, 06 2018 08:09
Notable earnings before Tuesday's open
AAC , ABC , ADM , AES , AFI , ANIP , APD , AVNS , BCC , BCPC , BDX , BHC , BIOS , BLD , BR , CORE , CTLT , CVS , ELAN , EMES , EMR , ETM , EXPD , FI , FRTA , FSS , GCP , GLDD , GLT , GOGO , GTN , GTX , HAE , HPT , HSIC , IONS , IRWD , JELD , JLL , KEYW...
Source: SeekingAlpha
Date: November, 05 2018 17:30
The Biotech Bumps
We've turned the page to November, and investors across the globe may feel a bit of unconscious relief. Stock markets do fluctuate, but months like October are never fun. And that has been especially acute in biotech. Leading ETFs like IBB and XBI dropped ~15% and 18% respectively in October...
Source: SeekingAlpha
Date: November, 01 2018 08:00
Ironwood Pharmaceuticals to Host Third Quarter 2018 Investor Update Call
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its third quarter 2018 investor update conference call and webcast at 8:30 a.m. Eastern Time on Tuesday, November 6, 2018. Individuals interested in participating in the call should dial (877) 643-7155 (U.S. and C...
Source: Business Wire
Date: October, 25 2018 17:00
Ironwood Pharmaceuticals receives Fast Track Designation for praliciguat for the treatment of HFpEF
The FDA has granted Fast Track Designation to Ironwood Pharmaceuticals' (NASDAQ: IRWD ) praliciguat (IW-1973) for the treatment of patients with heart failure with preserved ejection fraction (HFpEF). More news on: Ironwood Pharmaceuticals, Inc., Healthcare stocks news, Stocks on th...
Source: SeekingAlpha
Date: September, 13 2018 09:03
Ironwood Pharmaceuticals Announces FDA Fast Track Designation for Praliciguat for the Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)
– Praliciguat Phase II trial in HFpEF continues to enroll patients with topline data expected in the second half of 2019 – Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotech company, today announced that the U.S. Food and Drug Administration (FDA) has ...
Source: Business Wire
Date: September, 13 2018 08:00
Ironwood Pharmaceuticals to Present at Upcoming September Investor Conferences
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present corporate updates at two upcoming investor conferences in September: 2018 Wells Fargo Healthcare Conference on Thursday, September 6, 2018 at 1:55 p.m. ET at the Westin Copley Place in Boston. 16 th Annual Morgan Stanley...
Source: Business Wire
Date: August, 28 2018 16:05

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1417.9818.1918.252517.241,276,025
2017-02-0315.5115.4215.55515.161,399,177
2017-02-0214.7415.4615.8714.742,352,626
2017-02-0114.3815.0715.1114.371,744,978
2017-01-3113.9014.3814.4813.861,404,367

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-11105,239404,85125.9945Cover
2018-12-10434,0081,087,99139.8908Short
2018-12-0786,720157,13555.1882Short
2018-12-06254,318343,46174.0457Short
2018-12-04139,288386,44236.0437Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on IRWD.


About Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)

Logo for Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $2,494,027,755 - 05/17/2018
  • Issue and Outstanding: 137,944,013 - 04/27/2018

 


Recent Filings from (NASDAQ: IRWD)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 06 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 06 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: August, 06 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: August, 06 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: July, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 01 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 14 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 14 2018

 

 


Daily Technical Chart for (NASDAQ: IRWD)

Daily Technical Chart for (NASDAQ: IRWD)


Stay tuned for daily updates and more on (NASDAQ: IRWD)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: IRWD)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in IRWD is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of IRWD and does not buy, sell, or trade any shares of IRWD. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/